| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
116 |
115 |
$42K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
288 |
285 |
$22K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
234 |
230 |
$20K |
| 99215 |
Prolong outpt/office vis |
20 |
18 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
159 |
158 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
13 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
59 |
58 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
41 |
41 |
$936.17 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24 |
24 |
$886.32 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
42 |
42 |
$651.42 |
| 87081 |
|
56 |
55 |
$510.72 |
| 99051 |
|
12 |
12 |
$300.12 |